Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|November 16, 2006
Selective modulation of Abeta42 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyondStefanie Leuchtenberger, Dirk Beher, Sascha Weggen
Trends in Pharmacological Sciences|September 29, 2007
NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?Sascha Weggen, Mark Rogers, Jason Eriksen
Trends in Pharmacological Sciences|July 2, 2010
Exploring the chemical space of gamma-secretase modulatorsHeiko Zettl, Sascha Weggen, Petra Schneider, et al.
Molecular Neurobiology|October 14, 2016
Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD MiceMelanie Hüttenrauch, Susanne Walter, Margie Kaufmann, et al.
Experimental Cell Research|May 25, 2013
Stx5 is a novel interactor of VLDL-R to affect its intracellular trafficking and processingTimo Wagner, Marco Dieckmann, Sebastian Jaeger, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2013
Membrane anchoring γ-secretase modulators with terpene-derived moietiesEva Christine Naumann, Stefan Göring, Isabella Ogorek, et al.
Current Neuropharmacology|July 17, 2012
Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's DiseaseBruno Bulic, Julia Ness, Stefanie Hahn, et al.
Pageof 8